Cargando…
Exploring the impact of the recombinant Escherichia coli strain on defensins antimicrobial activity: BL21 versus Origami strain
The growing emergence of microorganisms resistant to antibiotics has prompted the development of alternative antimicrobial therapies. Among them, the antimicrobial peptides produced by innate immunity, which are also known as host defense peptides (HDPs), hold great potential. They have been shown t...
Autores principales: | López-Cano, Adrià, Martínez-Miguel, Marc, Guasch, Judith, Ratera, Imma, Arís, Anna, Garcia-Fruitós, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082834/ https://www.ncbi.nlm.nih.gov/pubmed/35527241 http://dx.doi.org/10.1186/s12934-022-01803-7 |
Ejemplares similares
-
Transcriptional profiling of thymidine-producing strain recombineered from Escherichia coli BL21
por: Kim, Jin-Sook, et al.
Publicado: (2015) -
Enhancing the biosynthesis of riboflavin in the recombinant Escherichia coli BL21 strain by metabolic engineering
por: Fu, Bing, et al.
Publicado: (2023) -
A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins
por: López-Cano, Adrià, et al.
Publicado: (2023) -
Complete Genome Sequence of Escherichia coli Strain BL21
por: Jeong, Haeyoung, et al.
Publicado: (2015) -
Metabolic engineering of Escherichia coli BL21 strain using simplified CRISPR-Cas9 and asymmetric homology arms recombineering
por: Shukal, Sudha, et al.
Publicado: (2022)